Arch Biopartners Inc. (TSXV:ARCH)
1.320
+0.050 (3.94%)
At close: Jan 9, 2026
Revenue by Product
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Revenue by Geography
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.